4 Breast Cancer Clinical Trials in Stamford, CT (2026)

Q: How do I join a clinical trial in Stamford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Stamford research site will contact you.

Recruiting Breast Cancer Studies in Stamford

NCT07391774Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high anatomic stage breast...

Stamford, CTPHASE31,978 participantsNational Cancer Institute (NCI)

View Study Details

NCT06312176Recruiting

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone rece...

Stamford, CTPHASE31,200 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06551116Recruiting

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

This study will assess whether a quantitative, HER2 assay can accurately and reliably discriminate between responders and non-responders among patients with HER2 IHCI+ metastatic breast cancer who are...

Stamford, CT200 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT04468061Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts ...

Stamford, CTPHASE2110 participantsDana-Farber Cancer Institute

View Study Details

About Breast Cancer Clinical Trials in Stamford

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 4 breast cancer clinical trials recruiting participants in Stamford, CT. These studies are seeking a combined 3,488 participants. Research is being sponsored by National Cancer Institute (NCI), Merck Sharp & Dohme LLC, Abramson Cancer Center at Penn Medicine and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Stamford — FAQ

Are there breast cancer clinical trials in Stamford?

Yes, there are 4 breast cancer clinical trials currently recruiting in Stamford, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stamford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stamford research site will contact you about next steps.

Are clinical trials in Stamford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stamford studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 4 active trials in Stamford are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 22, 2026 from ClinicalTrials.gov